Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1822]
News [2728]
Articles [201]
Editorials [1]
Conferences [136]
elearning [13]
Ensuring quality care for breast cancer patients globally
Dr Didier Verhoeven - University of Antwerp, Antwerp, Belgium
Ensuring quality care for breast cancer patients globally ( Dr Didier Verhoeven - University of Antwerp, Antwerp, Belgium )
1 Jun 2020
Venetoclax with bortezomib and dexamethasone in relapsed/refractory multiple...
Dr Shaji Kumar - Mayo Clinic, Rochester, USA
Venetoclax with bortezomib and dexamethasone in relapsed/refractory multiple myeloma ( Dr Shaji Kumar - Mayo Clinic, Rochester, USA )
1 Jun 2020
KRd vs VRd for initial therapy of newly diagnosed multiple myeloma
Dr Shaji Kumar - Mayo Clinic, Rochester, USA
KRd vs VRd for initial therapy of newly diagnosed multiple myeloma ( Dr Shaji Kumar - Mayo Clinic, Rochester, USA )
1 Jun 2020
Teclistamab for patients with heavily pretreated relapsed or refractory...
Dr Saad Usmani - Levine Cancer Institute, Charlotte, USA
Teclistamab for patients with heavily pretreated relapsed or refractory multiple myeloma ( Dr Saad Usmani - Levine Cancer Institute, Charlotte, USA )
1 Jun 2020
KEYNOTE-604: Pembrolizumab plus etoposide and platinum as a first-line therapy...
Dr Charles Rudin - Memorial Sloan Kettering Cancer Center, New York City, USA
KEYNOTE-604: Pembrolizumab plus etoposide and platinum as a first-line therapy for extensive-stage small-cell lung cancer ( Dr Charles Rudin - Memorial Sloan Kettering Cancer Center, New York City, USA )
31 May 2020
EAU guidelines for treating patients with advanced prostate cancer
Dr Eleni Efstathiou, Prof Álvaro Pinto, Prof Nicolas Mottet and Prof Heather...
EAU guidelines for treating patients with advanced prostate cancer ( Dr Eleni Efstathiou, Prof Álvaro Pinto, Prof Nicolas Mottet and Prof Heather Payne )
31 May 2020
LuPSMA vs cabazitaxel in metastatic castration-resistant prostate cancer...
Prof Michael Hofman - Peter MacCallum Cancer Centre, Melbourne, Australia
LuPSMA vs cabazitaxel in metastatic castration-resistant prostate cancer progressing after docetaxel ( Prof Michael Hofman - Peter MacCallum Cancer Centre, Melbourne, Australia )
30 May 2020
Maintenance avelumab plus best supportive care (BSC) versus BSC alone after...
Prof Thomas Powles - Barts Cancer Institute, London, UK
Maintenance avelumab plus best supportive care (BSC) versus BSC alone after chemotherapy in advanced urothelial carcinoma ( Prof Thomas Powles - Barts Cancer Institute, London, UK )
29 May 2020
Brigatinib for NSCLC, latest research and overcoming complications
Dr Ross Camidge - University of Colorado Cancer Center, Aurora, USA
Brigatinib for NSCLC, latest research and overcoming complications ( Dr Ross Camidge - University of Colorado Cancer Center, Aurora, USA )
29 May 2020
Update from KAITLIN for high-risk HER2-positive early breast cancer
Dr Julie Gralow - University of Washington School of Medicine, Seattle, USA
Update from KAITLIN for high-risk HER2-positive early breast cancer ( Dr Julie Gralow - University of Washington School of Medicine, Seattle, USA )
29 May 2020
Cisplatin plus/minus veliparib in metastatic TNBC and/or germline BRCA...
Dr Julie Gralow - University of Washington School of Medicine, Seattle, USA
Cisplatin plus/minus veliparib in metastatic TNBC and/or germline BRCA-associated breast cancer ( Dr Julie Gralow - University of Washington School of Medicine, Seattle, USA )
29 May 2020
Better genetic diagnostics in Ugandan breast cancer patients
Dr Julie Gralow - University of Washington School of Medicine, Seattle, USA
Better genetic diagnostics in Ugandan breast cancer patients ( Dr Julie Gralow - University of Washington School of Medicine, Seattle, USA )
29 May 2020

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation